Topic: pulmonary arterial hypertension
Kv11.1 channels, which are targeted by Pfizer's anti-arrhythmia drug Tikosyn (dofetilide), are also implicated in PAH, scientists have found.
After ponying up more than $800 million on its deal with Reata Pharmaceuticals, AbbVie is calling it quits.
The respiratory franchise bore the brunt of the cuts at a time when some GSK staff were questioning the wisdom of investing in the field.
United Therapeutics is throwing its pulmonary arterial hypertension drug esuberaprost on the scrap heap after failing in a phase 3 test.
The FDA granted Bayer and Merck breakthrough device status for AI-based software that spots a rare form of pulmonary hypertension in CT scans.
Arena’s run of positive news continues, with a massive $800 million upfront deal with United for pulmonary arterial hypertension drug ralinepag.
PhaseBio raised $34 million to advance a treatment for pulmonary arterial hypertension and a reversal agent of AstraZeneca’s Brilinta.
Medtronic and United Therapeutics received approval for a fully implantable infusion pump filled with Remodulin for pulmonary arterial hypertension.
Liquidia's experimental, phase 3 pulmonary arterial hypertension candidate is a dry powder formulation of the active ingredient in United's Tyvaso.
United will eliminate a threat by taking control of a startup that has been fighting to invalidate its patents and attack its PAH franchise.